FindTrial
Sign In

Impact of donor sex on the outcomes of liver transplantation for hepatocellular carcinoma

Impact of donor sex on the outcomes of liver transplantation for hepatocellular carcinoma - donor sex and the outcomes of liver transplantation for hepatocellular carcinoma

Status
Active, not recruiting
Phases
Unknown
Study type
Unknown
Source
JPRN
Registry ID
JPRN-UMIN000040245
Enrollment
1000
Registered
2020-04-27
Start date
2020-04-27
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hepatocellular carcinoma

Interventions

None listed

Sponsors

Kyoto University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients with hepatocellular carcinoma who underwent liver transplantation in Japan between 1990/1/1~2017/12/31

Exclusion criteria

Exclusion criteria: Cases with missing values in the essential items (presence or absence of recurrence, number of days until recurrence, and donor sex) that are indispensable for evaluating the impact of donor sex on the primary endpoint (recurrence of hepatocellular carcinoma)

Design outcomes

Primary

MeasureTime frame
recurrence rate of hepatocellular carcinoma—

Secondary

MeasureTime frame
overall survival rate disease-specific survival rate recurrence-free survival rate—

Countries

Japan

Contacts

Public ContactKojiro Taura

Kyoto University Graduate School of Medicine Department of Surgery (Division of Hepato-Biliary-Pancreatic Surgery and Transplantation)

ktaura@kuhp.kyoto-u.ac.jp+81-75-751-3242

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026